The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system

Abstract

The gut microbiota has emerged as an environmental factor that modulates the development of the central nervous system (CNS) and the enteric nervous system (ENS). Before obtaining its own microbiota, eutherian foetuses are exposed to products and metabolites from the maternal microbiota. At birth, the infants are colonised by microorganisms. The microbial composition in early life is strongly influenced by the mode of delivery, the feeding method, the use of antibiotics and the maternal microbial composition. Microbial products and microbially produced metabolites act as signalling molecules that have direct or indirect effects on the CNS and the ENS. An increasing number of studies show that the gut microbiota can modulate important processes during development, including neurogenesis, myelination, glial cell function, synaptic pruning and blood‐brain barrier permeability. Furthermore, numerous studies indicate that there is a developmental window early in life during which the gut microbial composition is crucial and perturbation of the gut microbiota during this period causes long‐lasting effects on the development of the CNS and the ENS. However, other functions are readily modulated in adult animals, including microglia activation and neuroinflammation. Several neurobehavioural, neurodegenerative, mental and metabolic disorders, including Parkinson disease, autism spectrum disorder, schizophrenia, Alzheimer's disease, depression and obesity, have been linked to the gut microbiota. This review focuses on the role of the microorganisms in the development and function of the CNS and the ENS, as well as their potential role in pathogenesis.

Parkinson's Disease: A Comprehensive Analysis of Fungi and Bacteria in Brain Tissue

“…However, the direct demonstration that these pathogens are present in brain tissue of PD patients was not provided. A possible link between the gut microbiota and neurodegeneration has also been developed in recent years [36][37][38]. Thus, the gut microbiota can influence CNS functioning, microglia activation and, in some instances, may lead to the synthesis of metabolites that provoke the pathological communication of gut microbes with microglia in the CNS and induce degeneration by the synthesis of toxic molecules.…”

Pioglitazone Attenuates Experimental Colitis-Associated Hyperalgesia through Improving the Intestinal Barrier Dysfunction

“…Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are characterized by diarrhea, weight loss, and chronic pain. IBD result in debilitating illness [1], among which chronic pain [2] emerges from the hyperresponsiveness of neuronal, immune, and endocrine signaling pathways within the intestines, the peripheral [3], and the central nervous system [4]. However, the mechanisms underlying IBD-associated chronic pain are largely unresolved and treatment options are limited.…”

Hidden Aspects of the Research-ADOS are Bound to Affect Autism Science

“…Yet, invariably, when we test the children in basic scientific research labs, using high grade instruments, we do find visual, hearing and touch impairments that would surely interfere with the use of the materials in this test. These highly quantifiable problems with their somatic and sensory motor systems are the tip of the iceberg, as deeper problems are present with their enteric nervous systems (the gut) and microbiome [74; 75; 76; 77; 78]. Many suffer from pain and temperature dysregulation as their overall sense of touch, vestibular issues with balance and multi-sensory integration overwhelms them in ways that we can now precisely quantify in personalized manner.…”